Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform
PrecisionSphere™ demonstrates efficacy and safety in drug delivery and is ready for commercial use, following the recent United States Food and Drug Administration’s (U.S. FDA) approval for the first product developed with this platform.




















